Advantage Alpha Capital Partners’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$398K	Sell	2,894 -675	-19%	-$92.8K	0.11%	105
2025 Q1	$643K	Buy	+3,569	New	+$643K	0.16%	95
2024 Q4	–	Sell	-2,289	Closed	-$417K	–	170
2024 Q3	$417K	Buy	+2,289	New	+$417K	0.09%	148